Jump to main content
Jump to site search

Issue 2, 2018
Previous Article Next Article

The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer

Author affiliations

Abstract

Recent research studies have shown that the intestinal flora are related to the occurrence and progress of breast cancer. This study investigates the effect of fucoidan on intestinal flora and intestinal barrier function in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancers. Sixty female Sprague-Dawley rats were randomly assigned to the control group, the model group, and the F1 and F2 groups, which were fed fucoidan at concentrations of 200 and 400 mg per kg bw (body weight), respectively. Intestinal histopathological analysis was performed and 16S rDNA high-throughput sequencing was used to provide an overview of the intestinal flora composition. The contents of D-lactic acid (D-LA), diamine oxidase (DAO) and endotoxin in plasma were detected by ELISA. Expression levels of the tight junction (TJ) proteins, phosphorylated p38 MAPK and ERK1/2 were measured using western blotting. Our results suggested that the intestinal wall of the model group was damaged. However, after fucoidan intervention, the villi were gradually restored. ELISA showed that the levels of plasma endotoxin, D-LA and DAO decreased in the F1 and F2 groups compared to those in the model group. Fucoidan treatment also increased the expressions of ZO-1, occludin, claudin-1 and claudin-8. Furthermore, the expression levels of phosphorylated p38 MAPK and ERK1/2 were upregulated in fucoidan treatment groups. The results of 16S rDNA high-throughput sequencing indicated that fucoidan increased the diversity of the intestinal microbiota and induced changes in microbial composition, with the increased Bacteroidetes/Firmicutes phylum ratio. In conclusion, the supplement of fucoidan could improve the fecal microbiota composition and repair the intestinal barrier function. The study suggested the use of fucoidan as an intestinal flora modulator for potential prevention of breast cancer.

Graphical abstract: The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer

Back to tab navigation

Publication details

The article was received on 25 Oct 2017, accepted on 09 Jan 2018 and first published on 10 Jan 2018


Article type: Paper
DOI: 10.1039/C7FO01677H
Citation: Food Funct., 2018,9, 1214-1223
  •   Request permissions

    The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer

    M. Xue, X. Ji, H. Liang, Y. Liu, B. Wang, L. Sun and W. Li, Food Funct., 2018, 9, 1214
    DOI: 10.1039/C7FO01677H

Search articles by author

Spotlight

Advertisements